Home
    • Plans Blog Contact
    Elevance Health Inc logo

    Elevance Health Inc

    ELV
    Last price US$378.21
    Market cap US$90.7b
    12M price change 34.01%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    UnitedHealth Group IncorporatedUNH Industry peer Molina Healthcare IncMOH Industry peer CVS Health CorpCVS Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Elevance Health Inc Overview

    Industry: Healthcare Plans

    Sector: Healthcare

    Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana. Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and re Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Elevance Health Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jul 15, 2026

    Quarterly result summary

    Revenue was $49.8B (+0.8% YoY); EPS was $27 (reported).

    Revenue $49.8B +0.8% YoY
    EPS $27 reported
    Net income $1.5B -17% YoY

    What changed

    • Revenue +0.8% YoY to $49.8B; EPS reported to $27.
    • Net income -17% YoY to $1.5B.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Jul 15, 2026 SEC filing 8-K Jul 15, 2026 SEC filing 10-Q Apr 22, 2026 SEC filing 8-K Apr 22, 2026 Earnings release Earnings release Apr 22, 2026 SEC filing 10-K Feb 06, 2026 SEC filing 8-K Jan 28, 2026 Earnings release Earnings release Jan 28, 2026 SEC filing 8-K Oct 21, 2025 SEC filing 10-Q Oct 21, 2025 Earnings release Earnings release Oct 21, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    Elevance Health Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Healthcare Plans industry , UnitedHealth Group Incorporated , Molina Healthcare Inc , CVS Health Corp are companies with high ratings.

    Return on Equity

    Score 4.47/5
    Elevance Health Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Elevance Hea... ELV US$90.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 3.50/5
    Elevance Health Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Elevance Hea... ELV US$90.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Healthcare Plans industry , UnitedHealth Group Incorporated , Molina Healthcare Inc , CVS Health Corp are companies with high ratings.

    Leverage

    Score 1.54/5
    Elevance Health Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    Elevance Hea... ELV US$90.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Elevance Health Inc logo

    Elevance Health Inc

    US$378.21

    US$94.65

    -75.0% vs price

    US$90.7b

    1.57%

    34.01%